Not Happily Ever After: Complications of chronic haemolysis in paroxysmal nocturnal haemoglobinuria patients on eculizumab

被引：0
|
作者：
Hsu, C. H. -W. [1 ]
Proven, M. [2 ]
Eglinton, J. [3 ]
机构：
[1] Univ Cambridge, Sch Clin Med, Cambridge, England
[2] John Radcliffe Hosp, Natl Haemoglobinopathy Reference Lab, Oxford, England
[3] Johnn Radcliffe, Natl Haemoglobinopathy Reference Lab, Oxford, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷
关键词：
Complement; Gallstone; Haemolysis; Monoclonal antibody; Pancreatitis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH18-EP-0
引用
收藏
页码：202 / 203
页数：2
相关论文
共 50 条
  • [41] Significant disease burden in paroxysmal nocturnal haemoglobinuria (PNH) patients with lower levels of haemolysis, mild anaemia and minimal transfusion: clinical improvement with eculizumab therapy
    Hill, A.
    Bessler, M.
    Schrezenmeier, H.
    Maciejewski, J. P.
    Rollins, S. A.
    Young, N. S.
    Luzzatto, L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 66 - 67
  • [42] Complement inhibition with Eculizumab affects fibrinogen levels and clot Structure in patients with Paroxysmal Nocturnal Haemoglobinuria
    Macrae, F.
    Bowman, P.
    Linton, E.
    Peacock-Young, B.
    Clarke, D.
    Newton, D.
    McKinley, C.
    Riley, K.
    Copeland, N.
    Arnold, L.
    Ariens, R.
    Hill, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 130 - 130
  • [43] Thrombotic complications in paroxysmal nocturnal haemoglobinuria: a literature review
    Malato, Alessandra
    Saccullo, Giorgia
    Lo Coco, Lucio
    Mancuso, Salvatrice
    Santoro, Marco
    Martino, Samuela
    Zammit, Valentina
    Sprini, Delia
    Siragusa, Sergio
    BLOOD TRANSFUSION, 2012, 10 (04) : 428 - 435
  • [44] Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
    Hillmen, Peter
    Muus, Petra
    Roeth, Alexander
    Elebute, Modupe O.
    Risitano, Antonio M.
    Schrezenmeier, Hubert
    Szer, Jeffrey
    Browne, Paul
    Maciejewski, Jaroslaw P.
    Schubert, Joerg
    Urbano-Ispizua, Alvaro
    de Castro, Carlos
    Socie, Gerard
    Brodsky, Robert A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (01) : 62 - 73
  • [45] Complement-mediated haemolysis and the role of blood transfusion in paroxysmal nocturnal haemoglobinuria
    Olutogun, Tolulase
    Cutini, Ilaria
    Notaro, Rosario
    Luzzatto, Lucio
    BLOOD TRANSFUSION, 2015, 13 (03) : 363 - 369
  • [46] Low Level Residual Extravascular Haemolysis Is Common Following Eculizumab Treatment In Paroxysmal Nocturnal Haemoglobinuria(PNH), but Does Not Affect Transfusion Requirement
    Kulasekararaj, Austin G.
    Odunsi, Dupe
    Krishnamurthy, Pramila
    Janet, Hayden
    Momoh, Ibrahim
    Mufti, Ghulam J.
    Marsh, Judith C. W.
    Elebute, Modupe
    BLOOD, 2010, 116 (21) : 1721 - 1722
  • [47] Sustained control of haemolysis and symptoms and reduced transfusion requirements over a period of 2 years in paroxysmal nocturnal haemoglobinuria (PNH) with eculizumab therapy
    Hill, A
    Elebute, D
    Marsh, JC
    Richards, SJ
    Mcnutt, B
    Petro, BE
    Rother, RP
    Hillmen, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 81 - 82
  • [48] A cascade of thromboembolic processes in a patient with paroxysmal nocturnal haemoglobinuria terminated by treatment with eculizumab
    Schutgens, Roger E. G.
    Pruissen-Peeters, Kim A. B. M.
    Muus, Petra
    THROMBOSIS AND HAEMOSTASIS, 2011, 106 (02) : 383 - 385
  • [49] Managing paroxysmal nocturnal haemoglobinuria (PNH) in pregnancy in the eculizumab era: a case series
    Dillon, A. M.
    Swallow, G. A.
    Myers, B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 35 - 35
  • [50] Paroxysmal nocturnal haemoglobinuria treatment with eculizumab is associated with a positive direct antiglobulin test
    Hoechsmann, B.
    Leichtle, R.
    von Zabern, I.
    Kaiser, S.
    Flegel, W. A.
    Schrezenmeier, H.
    VOX SANGUINIS, 2012, 102 (02) : 159 - 166
12345